Jefferies Group’s Tarsus Pharmaceuticals TARS Stock Holding History

Jefferies Group’s Portfolio TARS Stock Details TARS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$7.63M	Buy	445,758 +43,000	+11%	+$683K	0.06%	253
2022 Q2	$5.88M	Hold	402,758	–	–	0.05%	320
2022 Q1	$6.77M	Sell	402,758 -20,235	-5%	-$376K	0.04%	333
2021 Q4	$9.52M	Hold	422,993	–	–	0.06%	280
2021 Q3	$9.12M	Sell	422,993 -20,000	-5%	-$495K	0.07%	282
2021 Q2	$12.8M	Buy	+442,993	New	+$13.8M	0.08%	213

Other funds holding TARS

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jefferies Group's TARS Position: Q3 2022 in Review

Jefferies Group increased its Tarsus Pharmaceuticals (TARS) stake by 11% in Q3 2022, buying an estimated $683K and bringing the position to 445,758 shares worth $7.63M. The position accounts for 0.06% of the portfolio, ranked #253.

Jefferies Group first reported a position in TARS in Q2 2021 and has held it in 6 quarters since. The position peaked at $12.8M in Q2 2021. 75 funds tracked by Wall St. Rank hold TARS as of Q3 2022.

Jefferies Group held 445,758 shares of Tarsus Pharmaceuticals worth $7.63M as of Q3 2022.
Jefferies Group bought 43,000 Tarsus Pharmaceuticals shares in Q3 2022, an estimated $683K.
Tarsus Pharmaceuticals made up 0.06% of Jefferies Group's portfolio in Q3 2022, its #253 holding.
Jefferies Group first reported a position in Tarsus Pharmaceuticals in Q2 2021 and has held it in 6 quarters since.
Jefferies Group's Tarsus Pharmaceuticals position peaked at $12.8M in Q2 2021.
75 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.